Ellis Investment Partners’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,443
Closed -$279K 239
2023
Q4
$279K Buy
2,443
+8
+0.3% +$798 0.06% 174
2023
Q3
$222K Buy
2,435
+8
+0.3% +$825 0.06% 186
2023
Q2
$273K Buy
2,427
+8
+0.3% +$846 0.07% 175
2023
Q1
$253K Buy
2,419
+8
+0.3% +$835 0.07% 177
2022
Q4
$267K Buy
2,411
+7
+0.3% +$734 0.07% 172
2022
Q3
$210K Buy
2,404
+8
+0.3% +$727 0.06% 186
2022
Q2
$187K Buy
2,396
+10
+0.4% +$826 0.05% 210
2022
Q1
$203K Buy
2,386
+8
+0.3% +$766 0.05% 213
2021
Q4
$285K Buy
2,378
+6
+0.3% +$745 0.07% 180
2021
Q3
$293K Buy
2,372
+5
+0.2% +$643 0.07% 168
2021
Q2
$284K Sell
2,367
-1,895
-44% -$216K 0.07% 166
2021
Q1
$448K Buy
4,262
+12
+0.3% +$1.22K 0.12% 127
2020
Q4
$433K Buy
4,250
+11
+0.3% +$1.03K 0.13% 121
2020
Q3
$356K Buy
4,239
+14
+0.3% +$1.09K 0.13% 122
2020
Q2
$268K Buy
+4,225
New +$279K 0.1% 132

Other funds holding XYL

Ellis Investment Partners's XYL Position: Q1 2024 in Review

Ellis Investment Partners sold out of Xylem (XYL) in Q1 2024, closing a stake of 2,443 shares — an estimated $279K sold.

Ellis Investment Partners first reported a position in XYL in Q2 2020 and held it in 15 quarters. The position peaked at $448K in Q1 2021. 987 funds tracked by Wall St. Rank hold XYL as of Q1 2024.

  • Ellis Investment Partners reported no remaining Xylem position as of Q1 2024 after selling out during the quarter.
  • Ellis Investment Partners sold 2,443 Xylem shares in Q1 2024, an estimated $279K.
  • Ellis Investment Partners first reported a position in Xylem in Q2 2020 and held it in 15 quarters.
  • Ellis Investment Partners's Xylem position peaked at $448K in Q1 2021.
  • 987 funds tracked by Wall St. Rank held Xylem as of Q1 2024.

Based on Ellis Investment Partners's 13F filing for Q1 2024, filed 15 Apr 2024.